Skip to main navigation Skip to search Skip to main content

Timing of Screening Benefit for Lung Cancer With Low-Dose CT Imaging

  • Yang Xie
  • , Yiyin Zhang
  • , Peng Zhang
  • , Yiting Li
  • , Baichuan Xu
  • , Fang Shao
  • , Yingying Zhang
  • , Tian Yang
  • , Jiansheng Li
  • , Chao Li
  • , Tao Chen
  • Henan University of Chinese Medicine
  • Nanjing Medical University
  • University of York
  • First Affiliated Hospital of Xi 'An Jiaotong University
  • Xi'an Jiaotong University

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background
Increasing evidence supports lung cancer screening with low-dose CT (LDCT) imaging. However, the benefits of LDCT screening for lung cancer may not be immediate, making it unlikely to benefit patients with limited life expectancy.
Research Question
What is the time to benefit (TTB) from LDCT screening for individuals at high risk for lung cancer?
Original languageEnglish
Pages (from-to)1049-1056
Number of pages8
JournalChest
Volume168
Issue number4
Early online date18 Jun 2025
DOIs
Publication statusPublished - 1 Oct 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • clinical benefit
  • low-dose CT
  • lung cancer
  • screening

Fingerprint

Dive into the research topics of 'Timing of Screening Benefit for Lung Cancer With Low-Dose CT Imaging'. Together they form a unique fingerprint.

Cite this